Naoko Hosono
- Hematology top 5%
- Acute Myeloid Leukemia Research 34
- Chronic Myeloid Leukemia Treatments 9
- Multiple Myeloma Research and Treatments 6
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 8
- Myeloproliferative Neoplasms: Diagnosis and Treatment 7
-
- Neutropenia and Cancer Infections 7
-
- Hematological disorders and diagnostics 5
-
- Bone and Joint Diseases 5
- Co-authors
- Hideki MakishimaJaroslaw P. MaciejewskiTakanori UedaBartlomiej PrzychodzenTakahiro YamauchiShinji KishiAkira YoshidaYasufumi Matsuda
- Cited by
- HematologyGeneticsImmunology
- Partner nations
- JapanUnited StatesItaly
In The Last Decade
Naoko Hosono
52 papers receiving 640 citations
Peers
Comparison fields: 5 of 77
- Hematology 341
- Genetics 129
- Immunology 111
- Nephrology 35
- Molecular Biology 317
Countries citing papers authored by Naoko Hosono
This map shows the geographic impact of Naoko Hosono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoko Hosono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoko Hosono more than expected).
Fields of papers citing papers by Naoko Hosono
This network shows the impact of papers produced by Naoko Hosono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoko Hosono. The network helps show where Naoko Hosono may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Naoko Hosono, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2022 | 27 | |
| 4 | 2021 | 7 | |
| 5 | 2021 | 4 | |
| 6 | 2020 | 0 | |
| 7 | 2020 | 8 | |
| 8 | 2020 | 2 | |
| 9 | 2020 | 6 | |
| 10 | 2020 | 4 | |
| 11 | 2020 | 9 | |
| 12 | 2019 | 10 | |
| 13 | 2019 | 6 | |
| 14 | 2017 | 2 | |
| 15 | 2016 | 18 | |
| 16 | 2015 | 33 | |
| 17 | Early relapse is associated with high serum soluble interleukin-2 receptor after the sixth cycle of R-CHOP chemotherapy in patients with advanced diffuse large B-cell lymphoma. | 2012 | 13 |
| 18 | 2009 | 20 | |
| 19 | 2008 | 0 | |
| 20 | Detection of aquatic birnavirus gene from marine fish using a combination of reverse transcription- and nested PCR | 1997 | 15 |
About Naoko Hosono
Naoko Hosono is a scholar working on Hematology, Genetics and Orthopedics and Sports Medicine, having authored 60 papers that have together received 646 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (34 papers), Chronic Myeloid Leukemia Treatments (9 papers), Chronic Lymphocytic Leukemia Research (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers), Neutropenia and Cancer Infections (7 papers), Multiple Myeloma Research and Treatments (6 papers), Hematological disorders and diagnostics (5 papers) and Bone and Joint Diseases (5 papers). The work is most often cited by research in Hematology (341 citations), Genetics (129 citations) and Immunology (111 citations). Naoko Hosono has collaborated with scholars based in Japan, United States and Italy. Frequent co-authors include Hideki Makishima, Jaroslaw P. Maciejewski, Takanori Ueda, Bartlomiej Przychodzen, Takahiro Yamauchi, Shinji Kishi, Akira Yoshida, Yasufumi Matsuda, Takahiro Yamauchi and Eiju Negoro.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.